Hypertension Disparities in Black Americans

Black Americans develop hypertension earlier in life and at higher rates than any other racial group in the United States. By age 55, more than half of Black adults have been diagnosed with high blood pressure. The disparity begins in young adulthood: Black adults aged 20–44 are 2.5 times more likely to have hypertension than white adults of the same age. By midlife, the gap narrows in relative terms but remains enormous in absolute impact, given the higher baseline rates.

Root causes include chronic stress from systemic racism — a phenomenon researchers have termed 'weathering,' in which the cumulative effects of discrimination accelerate biological aging and cardiovascular risk. Discriminatory housing policy concentrated Black families in neighborhoods with higher pollution, less green space, and greater food insecurity — all documented hypertension risk factors. Underdiagnosis and undertreated hypertension in primary care settings compound the problem.

Critically, the first-line medication recommendations differ for Black patients. The 2017 AHA/ACC guidelines specifically recommend thiazide diuretics or calcium channel blockers as preferred first-line agents for Black patients, rather than ACE inhibitors alone — which are less effective for blood pressure reduction in this population. Patient-physician race concordance improves adherence to these guidelines.